You are here: Home » Reuters » News
Business Standard

Aurobindo Pharma second-quarter profit rises 29 percent, beats estimates


(Reuters) - India's Aurobindo Pharma Ltd posted a better-than-expected 29 percent rise in quarterly profit on Thursday, helped by higher sales at its formulations business in the United States.Net profit after taxes and non-controlling interest was 7.81 billion rupees ($120.22 million) in the second quarter ended Sept. 30, compared with 6.06 billion rupees a year earlier, the Hyderabad-headquartered drugmaker said in a statement. Analysts on average had expected a profit of 6.87 billion rupees, Thomson Reuters data showed.U.S. formulations sales, which accounted for 47 percent of total ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Thu, November 09 2017. 21:50 IST